Next Article in Journal
Concise review of current concepts on nomenclature and pathophysiology of hepatic encephalopathy
 
 
Medicina is published by MDPI from Volume 54 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Lithuanian Medical Association, Lithuanian University of Health Sciences, and Vilnius University.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Clinical relevance of high sensitivity C-reactive protein in cardiology

by
Dalia Adukauskienė
1,*,
Aušra Čiginskienė
1,
Agnė Adukauskaitė
2,
Daiva Pentiokinienė
2,
Rimvydas Šlapikas
2 and
Indrė Čeponienė
2
1
Department of Intensive Care, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
2
Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
*
Author to whom correspondence should be addressed.
Medicina 2016, 52(1), 1-10; https://doi.org/10.1016/j.medici.2015.12.001
Submission received: 21 August 2015 / Revised: 8 December 2015 / Accepted: 22 December 2015 / Published: 15 January 2016

Abstract

Coping with cardiovascular diseases (CVD), which are of the main causes of death worldwide, has influenced investigation of high sensitivity CRP (hsCRP) and its role in pathogene- sis, prognosis and prevention of CVD. hsCRP can be synthesized in vascular endothelium, atherosclerotic plaques, and theory of inflammatory origin of atherosclerosis is being more widely debated, raising questions, whether higher hsCRP plasma concentration might be the cause or the consequence. Summing up controversial data from multiple studies, guidelines recommend hsCRP testing for both, primary (stratifying CVD risk groups, selecting patients for statin therapy) and secondary CVD prevention (prognosis of CVD and its treatment complications, evaluation of treatment efficacy in moderate CVD risk group). hsCRP testing also has role in heart failure, atrial fibrillation, arterial hypertension, valve pathology and prognosis of coronary stent thrombosis or restenosis. Medications (the well-known and the new specific – CRP binding) affecting its concentration are being investigated as well.
Keywords: C-reactive protein; High sensitivity C-reactive protein; Cardiology; Ischemic heart disease C-reactive protein; High sensitivity C-reactive protein; Cardiology; Ischemic heart disease

Share and Cite

MDPI and ACS Style

Adukauskienė, D.; Čiginskienė, A.; Adukauskaitė, A.; Pentiokinienė, D.; Šlapikas, R.; Čeponienė, I. Clinical relevance of high sensitivity C-reactive protein in cardiology. Medicina 2016, 52, 1-10. https://doi.org/10.1016/j.medici.2015.12.001

AMA Style

Adukauskienė D, Čiginskienė A, Adukauskaitė A, Pentiokinienė D, Šlapikas R, Čeponienė I. Clinical relevance of high sensitivity C-reactive protein in cardiology. Medicina. 2016; 52(1):1-10. https://doi.org/10.1016/j.medici.2015.12.001

Chicago/Turabian Style

Adukauskienė, Dalia, Aušra Čiginskienė, Agnė Adukauskaitė, Daiva Pentiokinienė, Rimvydas Šlapikas, and Indrė Čeponienė. 2016. "Clinical relevance of high sensitivity C-reactive protein in cardiology" Medicina 52, no. 1: 1-10. https://doi.org/10.1016/j.medici.2015.12.001

APA Style

Adukauskienė, D., Čiginskienė, A., Adukauskaitė, A., Pentiokinienė, D., Šlapikas, R., & Čeponienė, I. (2016). Clinical relevance of high sensitivity C-reactive protein in cardiology. Medicina, 52(1), 1-10. https://doi.org/10.1016/j.medici.2015.12.001

Article Metrics

Back to TopTop